517 related articles for article (PubMed ID: 6324995)
1. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
2. Induction of anchorage-independent growth of JB6 mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.
Hosoi J; Abe E; Suda T; Colburn NH; Kuroki T
Cancer Res; 1986 Nov; 46(11):5582-6. PubMed ID: 3019530
[TBL] [Abstract][Full Text] [Related]
3. The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3.
Miller GJ; Stapleton GE; Ferrara JA; Lucia MS; Pfister S; Hedlund TE; Upadhya P
Cancer Res; 1992 Feb; 52(3):515-20. PubMed ID: 1370648
[TBL] [Abstract][Full Text] [Related]
4. 1 Alpha,25-dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor.
Baran DT; Sorensen AM; Shalhoub V; Owen T; Oberdorf A; Stein G; Lian J
J Bone Miner Res; 1991 Dec; 6(12):1269-75. PubMed ID: 1665280
[TBL] [Abstract][Full Text] [Related]
5. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
Koga M; Eisman JA; Sutherland RL
Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048
[TBL] [Abstract][Full Text] [Related]
6. The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro.
Lointier P; Wargovich MJ; Saez S; Levin B; Wildrick DM; Boman BM
Anticancer Res; 1987; 7(4B):817-21. PubMed ID: 2823686
[TBL] [Abstract][Full Text] [Related]
7. The ovary: a target organ for 1,25-dihydroxyvitamin D3.
Dokoh S; Donaldson CA; Marion SL; Pike JW; Haussler MR
Endocrinology; 1983 Jan; 112(1):200-6. PubMed ID: 6291916
[TBL] [Abstract][Full Text] [Related]
8. High performance liquid chromatography analysis of 1,25-dihydroxyvitamin D3 receptor in malignant cells. Correlation of effects on cell proliferation and receptor concentration.
Thomas GA; Simpson RU
Cancer Biochem Biophys; 1986 Jul; 8(3):221-34. PubMed ID: 3017543
[TBL] [Abstract][Full Text] [Related]
9. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
10. 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production.
Provvedini DM; Tsoukas CD; Deftos LJ; Manolagas SC
J Immunol; 1986 Apr; 136(8):2734-40. PubMed ID: 3007606
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of 1 alpha,25-dihydroxyvitamin D3 receptor-like molecule in ST 13 and 3T3 L1 preadipocytes and its inhibitory effects on preadipocyte differentiation.
Sato M; Hiragun A
J Cell Physiol; 1988 Jun; 135(3):545-50. PubMed ID: 2840436
[TBL] [Abstract][Full Text] [Related]
12. The effect of 1,25-dihydroxyvitamin D3 on the cytoskeleton of rat calvaria and rat osteosarcoma (ROS 17/2.8) osteoblastic cells.
Gronowicz G; Egan JJ; Rodan GA
J Bone Miner Res; 1986 Oct; 1(5):441-55. PubMed ID: 3332554
[TBL] [Abstract][Full Text] [Related]
13. Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells.
Costa EM; Hirst MA; Feldman D
Endocrinology; 1985 Nov; 117(5):2203-10. PubMed ID: 2995009
[TBL] [Abstract][Full Text] [Related]
14. Temperature-dependent alteration of 1,25-dihydroxy-vitamin D3 receptor macromolecules in MC3T3-E1 cells: affinity of hexafluoro analog of 1,25-dihydroxyvitamin D3, ST-630, for these forms.
Tanaka M; Muramatsu M; Higuchi S; Otomo S
Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):3-13. PubMed ID: 7953192
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D affects proliferation of a murine T helper cell clone.
Lacey DL; Axelrod J; Chappel JC; Kahn AJ; Teitelbaum SL
J Immunol; 1987 Mar; 138(6):1680-6. PubMed ID: 3029220
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites.
Frampton RJ; Omond SA; Eisman JA
Cancer Res; 1983 Sep; 43(9):4443-7. PubMed ID: 6307514
[TBL] [Abstract][Full Text] [Related]
17. 1,25-dihydroxyvitamin D reduces parathyroid hormone receptor number in ROS 17/2.8 cells and prevents the glucocorticoid-induced increase in these receptors: relationship to adenylate cyclase activation.
Titus L; Jackson E; Nanes MS; Rubin JE; Catherwood BD
J Bone Miner Res; 1991 Jun; 6(6):631-7. PubMed ID: 1653516
[TBL] [Abstract][Full Text] [Related]
18. Biochemical significance of enhanced activity of fluorinated 1,25-dihydroxyvitamin D3 in human cultured cell lines.
Eisman JA; Frampton RJ; McLean FJ
Cell Biochem Funct; 1986 Apr; 4(2):115-22. PubMed ID: 3011306
[TBL] [Abstract][Full Text] [Related]
19. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
Levy Y; Knutson JC; Bishop C; Shany S
Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
[TBL] [Abstract][Full Text] [Related]
20. Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid.
Hosoi J; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Apr; 45(4):1474-8. PubMed ID: 2983883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
